Persistent AF, defined as at least one continuous AF episode lasting at least seven days in duration, documented by a continuous monitor or 2 ECGs\>7 days apart or ≥3 cardioversions
Indicated and interested in ICM implant for monitoring post ablation
Written informed consent obtained from subject and ability for subject to comply with the requirements of the study
You may not be if
Any prior atrial endocardial or epicardial ablation procedure, other than cavotricuspid isthmus ablation or supraventricular tachycardia
Stroke or transient ischemic attack within the previous six months
Gastrointestinal bleeding within the previous three months
Implanted pacemaker or defibrillator
Longstanding persistent AF (\> 3 years)
LA volume \>80ml/m2
Atrial septal occlusion device
Current left atrial thrombus
Left atrial appendage occlusion or closure device \< 6 mos or with leak or prior DRT
Mitral or Tricuspid valve clip or mechanical replacement or clip
Hypertrophic cardiomyopathy
Contraindication to femoral vascular access
Congenital heart disease with residual anatomic abnormality
Contraindication to, or unwillingness to use, systemic anticoagulation
Pregnancy
Left ventricular ejection fraction \<30%
Baseline creatinine \>2.0 mg/dL
Predicted life expectancy less than one year
Refusal to receive ICM implant or allergy to ICM
Clareo Health | PVI Alone Versus PVI Plus PWI and SVCI With PFA
